We help communities to created a custom knowledge base(still being refined)
Click here to view original web page at Multiple Sclerosis Drug Works in a Surprising Way
Summary: Interferon betas, a class of drugs commonly prescribed to those with multiple sclerosis reduces the binding of zinc, C-peptide, and albumin to red blood cells. Source: ACS Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a […]
Summary: Social support and social integration help improve overall health and well-being for those with multiple sclerosis. Source: Kessler Foundation Researchers conducted a comprehensive online survey of people with multiple sclerosis, assessing their health, lifestyle, personality, MS symptomatology, psychological well-being, social support, and social integration. Study findings suggest that […]
Summary: Study reveals an association between signal detection theory, brain activation patterns, and subjective state fatigue. In those with multiple sclerosis, greater effects of fatigue were seen. Source: Kessler Foundation Using signal detection theory, Kessler Foundation researchers furthered their understanding of the mechanisms of cognitive fatigue in a recent […]
Summary: In the first year after a diagnosis of multiple sclerosis, 60% of patients experience fatigue, 50% experience pain, 47% have symptoms of depression, and 39% report increased anxiety. Researchers say urgent, non-pharmaceutical therapies should be provided for newly diagnosed MS patients to help reduce both pain and mental […]
In a large-scale study, the use of the Simoa neurofilament light test helped identify individuals with MS at risk for detrimental disease course and suboptimal therapy response. The FDA has granted breakthrough device designation to Quanterix’s Simoa neurofilament light (NfL) chain test as a prognostic aid in assessing the […]
Nearly one million people in the U.S. are living with multiple sclerosis. SPRINGFIELD, MA (WGGB/WSHM) – Nearly one million people in the U.S. are living with multiple sclerosis. Dr. Hebatalla Elhusseiny, staff neurologist at the Joyce D. and Andrew J. Mandell Center for Comprehensive Multiple Sclerosis Care and Neuroscience […]
Dr. Cruz Multiple Sclerosis (MS) is the second most common cause of non-traumatic neurological disability in young adults. It is an autoimmune inflammatory disease of the central nervous system (CNS), this means that it is a disease where the immune system starts attacking the brain, optic nerves, and spinal […]
India is battling an unprecedented rise in neurological disorders. With nearly one in six of the world’s population suffering from such disorders, the alarming numbers point towards Alzheimer’s, Parkinson’s, Strokes, Multiple Sclerosis and Epilepsy to Migraines and several other neurological diseases. Among them, one of the commonest is Stroke. […]
Certain group 3 innate lymphoid cells (ILC3s)—immune cells that typically protect against gastrointestinal inflammation—may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a study published in Nature . The investigators said these results suggest that inhibiting the activity of these cells could […]
An immunological molecule called fractalkine can boost the production of brain cells that produce myelin, a key factor in diseases such as multiple sclerosis, according to recent research from the University of Alberta. Myelin is an insulating layer around nerves that is gradually worn away by inflammation in multiple […]
